Overview
Portfolio
More
Heran Partners
Antwerp, Belgium
Provides venture and growth capital to European health‑tech and med‑tech startups with strong enabling technologies, leveraging a network and mentorship to drive impact.
Portfolio
15+
Employees
10+
Founded
2020
AUM
≈ $83.1M
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
Europe
Fund details
Funds
Heran HealthTech Fund I
Vintage 2020 • $83.1M
Sources
Heran Partners
Provides venture and growth capital to European health‑tech and med‑tech startups with strong enabling technologies, leveraging a network and mentorship to drive impact.
Portfolio
15+
Employees
10+
Founded
2020
AUM
≈ $83.1M
Funds
Heran HealthTech Fund I · Vintage 2020 • $83.1M
Stages
No stages listed
Industries
No industries listedGeographic scope
Europe
Sources
Showing 10 of 10 matched portfolio companies
Amaron provides healthcare interoperability solutions using standards such as HL7® FHIR® and DICOM® to securely share medical data across various IT systems and institutions. By automating processes and reducing manual administrative tasks, Amaron enhances collaboration among healthcare professionals, ensuring timely access to critical patient information.
Aspect Analytics provides a unified platform for integrating and analyzing spatial multi-omics data across different modalities. This solution enables secure data storage, automated workflows, and parallel in-depth analysis for large datasets. The platform facilitates team collaboration through personalized dashboards and role-based access for reliable research outcomes.
Funding: $4.7M
Rough estimate of the amount of funding raised
Funding: $4.7M
Rough estimate of the amount of funding raised
This company develops genomic technology focused on improving the safety and characterization of gene editing tools for cell and gene therapies. Their INDUCE-seq platform enables developers to accurately detect on- and off-target edits associated with gene editing systems like CRISPR. This technology supports the standardization and acceleration of safer gene-edited therapeutic development.
Funding: $16.0M
Rough estimate of the amount of funding raised
Funding: $16.0M
Rough estimate of the amount of funding raised
Gynaia provides an integrated platform for gynecological ultrasound professionals that combines expert-led training and certification, quality assessment with de‑identified case reviews, and point‑of‑care decision‑support apps. Its Clinical Data Miner enables standardized data collection for multicenter research, while a curated case database and professional support help maintain diagnostic competence and improve patient outcomes.
Hypervision Surgical Ltd utilizes AI-powered hyperspectral imaging to provide real-time, non-invasive tissue characterization during surgeries, enhancing the precision of intraoperative decision-making. This technology addresses the challenge of subjective visual assessments by enabling clinicians to differentiate between tumor and healthy tissue, ultimately improving patient safety and surgical outcomes.
Funding: $8.8M
Rough estimate of the amount of funding raised
Funding: $8.8M
Rough estimate of the amount of funding raised
This company develops FDA-cleared, AI-driven software solutions for quantitative analysis of brain MRI scans in neurology. Their platform assists radiologists and neurologists by comparing and quantifying longitudinal imaging data to support data-driven clinical decision-making. The technology aims to improve the speed, consistency, and accuracy of monitoring neurological conditions like Multiple Sclerosis.
ImmuneSpec provides high-sensitivity immunopeptidomics analysis utilizing MAPPs technology for biotherapeutic development. This service enables accurate T cell epitope deciphering for comprehensive immunogenicity risk assessment. The company delivers scientifically rigorous results supporting target discovery, construct validation, and vaccine optimization.
Provides a federated data platform for healthcare organizations, enabling the integration and harmonization of structured and unstructured clinical data using NLP and OMOP CDM. This system supports real-world evidence generation and multicenter studies in oncology and cardiology, improving data quality and accelerating research while ensuring compliance with privacy regulations.
Funding: $26.7M
Rough estimate of the amount of funding raised
Funding: $26.7M
Rough estimate of the amount of funding raised
Nuclivision develops software solutions, including Nuclarity, designed to enhance nuclear medicine workflows. This technology aims to make nuclear medicine procedures faster, safer for patients, and more accessible. The software delivers enhanced PET images, improving patient safety and streamlining operations within imaging centers.
Funding: $430.0K
Rough estimate of the amount of funding raised
Funding: $430.0K
Rough estimate of the amount of funding raised
Velsera provides a diagnostic platform that automates DNA PCR analyses in molecular labs through modular tools for sample flow orchestration, result analysis, and quality control. This technology enhances lab efficiency by standardizing data analysis, reducing turnaround times, and increasing sample throughput.
Funding: $9.2M
Rough estimate of the amount of funding raised
Funding: $9.2M
Rough estimate of the amount of funding raised
Showing 5 of 5 unmatched portfolio companies
PharmaFluidics (Thermo Fisher Scientific)
thermofisher.comWe don't have a full profile for this company yet.